An evaluation study of efficacy and safety of Robotic pulmonary lobectomy with Da Vinci Surgical System for Lung cancer

An evaluation study of efficacy and safety of Robotic pulmonary lobectomy with Da Vinci Surgical System for Lung cancer - An evaluation of lung cancer surgery with Da Vinci

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030358

Enrollment

Registered

2017-12-15

Start date

2011-11-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Pulmonary lobectomy with Da Vinci Surgical System

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) radiologically judged Stage I lung cancer 2) applicable to video-assisted pulmonary lobectomy 3) age 20 to 80 years 4) ECOG-Performance status of 0 to 1 5) written informed consent

Exclusion criteria

Exclusion criteria: 1) history of thoracic surgery on ipsilateral side 2) severe cardiac or cerebral vascular disease 3) aspirin, warfarin or other medications induce bleeding tendency prohibited to discontinue 4) sever renal disfunction 5) severe hepatic disfunction 6) patients whose enrollement in this trial is judged to be inappropriate by the attending doctor

Design outcomes

Primary

Measure	Time frame
Perioperative Morbidity and Mortality(Clavien-Dindo classification 2 or higher)	—

Secondary

Measure	Time frame
Surgical outcomes (operation time, volume of blood loss, and conversion rate to open surgery)	—

Countries

Japan

Contacts

Public ContactKoji Yamazaki

National Hospital Organization Kyushu Medical Center Department of Thoracic Surgery

yamazaki@kyumed.jp092-852-0700

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026